Early Time Course of JV-Acetylaspartate , Creatine and Phosphocreatine , and Compounds Containing Choline in the Brain After Acute Stroke

Background and Purpose: The early time course after acute stroke of cerebral JV-acetylaspartate, creatine and phosphocreatine, and compounds containing choline was studied in vivo by means of localized water-suppressed proton magnetic resonance spectroscopy. Methods: Eight patients with acute stroke were studied serially in the acute phase, 1 week after, and 2-4 weeks after the onset of clinical symptoms. Ten healthy volunteers served as controls. A stimulated echo (STEAM) sequence was used for measurement of the brain metabolites in a volume of interest located within the infarcted area as visualized by magnetic resonance imaging. For quantification, the unsaturated water signal was used as the internal standard. Regional cerebral blood flow in the infarcted area was measured relative to a symmetrically located unaffected area by means of single-photon emission computed tomographic scanning, using Tc-labeled </,/-hexamethylenepropyleneamine oxime as the flow tracer. Results: Relative regional cerebral blood flow was considerably reduced in the infarcted area in the acute phase. After 1 week, hyperemia was seen in all but one patient. The iV-acetylaspartate content was significantly reduced, with the loss appearing to occur between 6 and 24 hours after the stroke incident. The reduction in JV-acetylaspartate content was greater in the central part than in the peripheral part of the infarcted area. Creatine and phosphocreatine were also reduced in the infarcted area, whereas no significant change was seen in the choline content. Conclusions: Assuming that A'-acetylaspartate content reflects neuronal survival or loss, our results may suggest that treatment procedures with restoration of blood flow to severely ischemic areas should be initiated within the first 6 hours after stroke onset. (Stroke 1992;23:1566-1572)

[1]  P. V. van Rijen,et al.  Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction. , 1988, Stroke.

[2]  A. Benabid,et al.  Two‐dimensional 1H spectroscopic imaging for evaluating the local metabolic response to focal ischemia in the conscious rat , 1992, NMR in biomedicine.

[3]  P A Bottomley,et al.  Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? , 1989, Radiology.

[4]  Richard S. J. Frackowiak,et al.  Acute Cerebral Ischaemia: Concurrent Changes in Cerebral Blood Flow, Energy Metabolites, pH, and Lactate Measured with Hydrogen Clearance and 31P and 1H Nuclear Magnetic Resonance Spectroscopy. II. Changes during Ischaemia , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Olaf B. Paulson,et al.  The Retention of [99mTc]-d,l-HM-PAO in the Human Brain after Intracarotid Bolus Injection: A Kinetic Analysis , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  R G Shulman,et al.  Proton Magnetic Resonance Spectroscopy of Cerebral Lactate and Other Metabolites in Stroke Patients , 1992, Stroke.

[7]  G B Matson,et al.  Human brain infarction: proton MR spectroscopy. , 1992, Radiology.

[8]  B. Drayer,et al.  Chronic adult cerebral infarction studied by phosphorus NMR spectroscopy. , 1986, Radiology.

[9]  Williams,et al.  Cerebral ischaemia studied by nuclear magnetic resonance spectroscopy. , 1989, Cerebrovascular and brain metabolism reviews.

[10]  P. Narayana,et al.  Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. , 1990, Investigative radiology.

[11]  K Suzuki,et al.  SUBACUTE SCLEROSING LEUKOENCEPHALITIS: II. CHEMICAL STUDIES INCLUDING ABNORMAL MYELIN AND AN ABNORMAL GANGLIOSIDE PATTERN , 1966, Journal of neuropathology and experimental neurology.

[12]  O. Henriksen,et al.  In vivo relaxation of N-acetyl-aspartate, creatine plus phosphocreatine, and choline containing compounds during the course of brain infarction: a proton MRS study. , 1992, Magnetic resonance imaging.

[13]  Alan C. Evans,et al.  The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts , 1987, Annals of neurology.

[14]  R. Crowell,et al.  Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys , 1981, Neurology.

[15]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[16]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[17]  O Henriksen,et al.  In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. , 1993, Magnetic resonance imaging.

[18]  J. Coyle,et al.  N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.

[19]  P A Narayana,et al.  In vivo proton magnetic resonance spectroscopy studies of human brain. , 1991, Magnetic resonance imaging.

[20]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[21]  B. Miller A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[22]  J. Frahm,et al.  On the identification of cerebral metabolites in localized 1H NMR spectra of human brain In vivo , 1991, NMR in biomedicine.

[23]  J. Frahm,et al.  Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.

[24]  T. Olsen,et al.  Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. , 1983, Stroke.

[25]  P. Tofts,et al.  A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy , 1988, NMR in biomedicine.

[26]  P M Matthews,et al.  Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.